Bexion Pharmaceuticals, CTI successfully complete first human trial on BXQ-350 treatment of cancer
Bexion Pharmaceuticals and CTI Clinical Trial and Consulting Services have successfully completed the First-in-Human Phase 1A clinical trial with BXQ-350…